About urokinase combined with low molecular weight heparin in the treatment of acute myocardial infarction analysis.docVIP

 PAGE \* MERGEFORMAT 4 About urokinase combined with low molecular weight heparin in the treatment of acute myocardial infarction analysis [Paper Keywords] Urokinase; low molecular weight heparin; cardiac embolism; primary hospital [Abstract] At present, acute myocardial infarction (acute myocardial infarction, AMI) in treatment and research hospitals above the county level has made great achievements, but in most rural primary hospital treatment for AMI is still in the custody of stages of treatment. This article aims to evaluate low molecular weight heparin in the treatment of urokinase combined with AMI’s efficacy and safety to explore this method in the primary hospital application. An object and method 1.1 Object thrombolytic therapy group: from June 2007 to June 2008 admitted to hospital for treatment of AMI in patients with deep-bolt 49 (male 30, female 19) patients, aged 39 to 75 years old, ≥ 70 years of age in 14 cases (29%); are in line with literature [1] in the case selection criteria. Control group: from May 2003 to May 2006 the incidence of hospitalization is not carried out within 12h of thrombolytic therapy in 48 patients with AMI (male 29, female 19) cases), age 46 ~ 76 years, ≥ 70 years of age in 14 cases (29% ). Two groups of age, sex, infarct location and onset time difference was not statistically significant. 1.2 Methods thrombolytic treatment groups: the first oral administration of water-soluble aspirin 0.3g, after the daily 0.15g, 5d was converted 0.1g, long-term use; urokinase (S amp;amp; P Pharmaceutical Co., Ltd. Guangdong days of production) 16.7 ~ 25mkat ( 1mkat = 60U) dissolved in saline 100ml, 30min vein infusion, thrombolytic therapy given after 12h low score heparin calcium (Sanofi Synthé labo Hangzhou Minsheng Pharmaceutical Co., Ltd. Production) 68 ~ 103μ kat abdominal subcutaneous injection, every 12b1 times, used in conjunction 5d; other treatments with the control group. Control group: oxygen, bed rest, ECG monito